Targeted therapy drugs could radically increase the costs of leukemia treatment

(Massachusetts General Hospital) A study by a Massachusetts General Hospital-led research team finds that, at current prices, adoption of novel oral targeted therapies for treatment of chronic lymphocytic leukemia could raise the treatment costs for the blood-system cancer in the US by almost 600 percent.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news